rs1805123

This is a variant in the KCNH2 gene that changes a lysine to an threonine.

GWAS Catalog Trait Associations (4)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

QT interval

Bihlmeyer NA et al. ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals. Circulation. Genomic and Precision Medicine 11(1):e001758 (2018)
Allele G
OR 1.47
p 7.0e-51
N 95,626
Large GWAS
multi-ancestry

body mass index

Huang J et al. Genomics and phenomics of body mass index reveals a complex disease network. Nature Communications 13(1):7973 (2022)
Allele G
OR 0.01
p 4.0e-21
N 1,122,049
Large GWAS
European
Allele G
OR 0.02
p 5.0e-15
N 526,508
Large GWAS
multi-ancestry
Allele G
OR 0.01
p 6.0e-12
N 394,642
Large GWAS
European

body height

Allele T
OR 0.01
p 4.0e-12
N 453,169
Large GWAS
European

triglyceride:HDL cholesterol ratio

Allele T
OR 0.02
p 9.0e-10
N 402,398
Major Consortium StudyLarge GWAS
European

ClinVar annotation

Benign★★★
4 submitters23 publications

Atrial fibrillation; Cardiac arrhythmia; Cardiovascular phenotype; Long QT syndrome (LQTS); Long QT syndrome 2 (LQT2); Short QT syndrome type 1; not specified

View on ClinVar →

About KCNH2

This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]

View all KCNH2 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…